Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Ambrisentan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 33,060Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurobindo Pharma Generic Ambrisentan Receives Approval in the U.S.
    Aurobindo Pharma Generic Ambrisentan Receives Approval in the U.S.

    21 Jul 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216531

    FDA
    21 Jul 2022
    Share Share
    Altavant Presents Data Showing on Combination Of Rodatristat Ethyl+Ambrisentan
    Altavant Presents Data Showing on Combination Of Rodatristat Ethyl+Ambrisentan

    06 May 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/altavant-sciences-presents-data-showing-potential-for-combination-of-rodatristat-ethyl-and-ambrisentan-in-model-of-pulmonary-arterial-hypertension-301541434.html

    PRNEWSWIRE
    06 May 2022
    Share Share
    FDA Explains Why it Waived a Shared REMS for Letairis Generics
    FDA Explains Why it Waived a Shared REMS for Letairis Generics

    06 May 2019

    // Zachary Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/5/fda-explains-why-it-waived-a-shared-rems-for-letai

    Zachary Brennan RAPS
    06 May 2019
    Share Share
    Sun Pharms INDS Generic Ambrisentan Receives Approval in US
    Sun Pharms INDS Generic Ambrisentan Receives Approval in US

    30 Mar 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210784

    FDA
    30 Mar 2019
    Share Share
    Zydus Pharms USA`s Generic Ambrisentan Receives Approval in US
    Zydus Pharms USA`s Generic Ambrisentan Receives Approval in US

    30 Mar 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210058

    FDA
    30 Mar 2019
    Share Share
    Mylan Pharms Generic Ambrisentan Approval in US
    Mylan Pharms Generic Ambrisentan Approval in US

    30 Mar 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208441

    FDA
    30 Mar 2019
    Share Share